diZerega GS - Search Results

1

Intratumoral Injection of Large Surface Area Microparticle Taxanes in Carcinomas Increases Immune Effector Cell Concentrations, Checkpoint Expression, and Synergy with Checkpoint Inhibitors: A Review of Preclinical and Clinical Studies.

diZerega GS, Maulhardt HA, Verco SJ, Marin AM, Baltezor MJ, Mauro SA, Iacobucci MA. diZerega GS, et al. Oncol Ther. 2024 Mar;12(1):31-55. doi: 10.1007/s40487-024-00261-y. Epub 2024 Jan 30. Oncol Ther. 2024. PMID: 38289576 Free PMC article. Review.

2

Intratumoral Treatment of Melanoma Tumors with Large Surface Area Microparticle Paclitaxel and Synergy with Immune Checkpoint Inhibition.

Maulhardt HA, Marin AM, diZerega GS. Maulhardt HA, et al. Among authors: dizerega gs. Int J Nanomedicine. 2024 Jan 22;19:689-697. doi: 10.2147/IJN.S449975. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38283196 Free PMC article.

3

Early phase trial of intracystic injection of large surface area microparticle paclitaxel for treatment of mucinous pancreatic cysts.

Othman M, Patel K, Krishna SG, Mendoza-Ladd A, Verco S, Abidi W, Verco J, Wendt A, diZerega G. Othman M, et al. Endosc Int Open. 2022 Dec 15;10(12):E1517-E1525. doi: 10.1055/a-1949-7730. eCollection 2022 Dec. Endosc Int Open. 2022. PMID: 36531683 Free PMC article.

4

Response of Locally Advanced Pancreatic Cancer to Intratumoral Injection of Large Surface Area Microparticle Paclitaxel: Initial Report of Safety and Clinical Outcome.

Sharma NR, Lo SK, Hendifar A, Othman MO, Patel K, Mendoza-Ladd A, Verco S, Maulhardt HA, Verco J, Wendt A, Marin A, Schmidt CM, diZerega G. Sharma NR, et al. Pancreas. 2023 Mar 1;52(3):e179-e187. doi: 10.1097/MPA.0000000000002236. Pancreas. 2023. PMID: 37782888 Clinical Trial.

5

Phase 1/2 Trial Results of a Large Surface Area Microparticle Docetaxel for the Treatment of High-Risk Nonmuscle-Invasive Bladder Cancer.

Kates M, Mansour AM, Lamm DL, Shore N, Maulhardt H, Wendt A, Verco J, Marin A, Dewnani K, Verco S, diZerega GS. Kates M, et al. Among authors: dizerega gs. J Urol. 2022 Oct;208(4):821-829. doi: 10.1097/JU.0000000000002778. Epub 2022 May 16. J Urol. 2022. PMID: 35574612 Clinical Trial.

6

Intratumoral submicron particle docetaxel inhibits syngeneic Renca renal cancer growth and increases CD4+, CD8+, and Treg levels in peripheral blood.

Maulhardt HA, Marin AM, diZerega GS. Maulhardt HA, et al. Among authors: dizerega gs. Invest New Drugs. 2020 Oct;38(5):1618-1626. doi: 10.1007/s10637-020-00922-5. Epub 2020 Mar 20. Invest New Drugs. 2020. PMID: 32198648 Free PMC article.

7

Local Injection of Submicron Particle Docetaxel is Associated with Tumor Eradication, Reduced Systemic Toxicity and an Immunologic Response in Uro-Oncologic Xenografts.

Maulhardt HA, Hylle L, Frost MV, Tornio A, Dafoe S, Drummond L, Quinn DI, Kamat AM, diZerega GS. Maulhardt HA, et al. Among authors: dizerega gs. Cancers (Basel). 2019 Apr 24;11(4):577. doi: 10.3390/cancers11040577. Cancers (Basel). 2019. PMID: 31022918 Free PMC article.

8

Development of a guinea pig cutaneous radiation injury model using low penetrating X-rays.

Rodgers KE, Tan A, Kim L, Espinoza T, Meeks C, Johnston W, Maulhardt H, Donald M, Hill C, diZerega GS. Rodgers KE, et al. Among authors: dizerega gs. Int J Radiat Biol. 2016 Aug;92(8):434-43. doi: 10.1080/09553002.2016.1186302. Epub 2016 Jun 3. Int J Radiat Biol. 2016. PMID: 27258737

9

NorLeu³-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers.

Rodgers KE, Bolton LL, Verco S, diZerega GS. Rodgers KE, et al. Among authors: dizerega gs. Adv Wound Care (New Rochelle). 2015 Jun 1;4(6):339-345. doi: 10.1089/wound.2014.0609. Adv Wound Care (New Rochelle). 2015. PMID: 26029484 Free PMC article. Review.

10

A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies.

Williamson SK, Johnson GA, Maulhardt HA, Moore KM, McMeekin DS, Schulz TK, Reed GA, Roby KF, Mackay CB, Smith HJ, Weir SJ, Wick JA, Markman M, diZerega GS, Baltezor MJ, Espinosa J, Decedue CJ. Williamson SK, et al. Among authors: dizerega gs. Cancer Chemother Pharmacol. 2015 May;75(5):1075-87. doi: 10.1007/s00280-015-2737-4. Epub 2015 Apr 23. Cancer Chemother Pharmacol. 2015. PMID: 25898813 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

206 results

Search Page